Anissa Boumlic-Courtade, PhD is the Vaccine Initiave Lead, EMEA with Merck. Dr. Boumlic-Courtade joined Merck in 2009. She has held various positions focused on downstream processing, virus safety, and monoclonal antibody and vaccine manufacturing.
Dr. Anissa Boumlic-Courtade holds a M. Sc. in Biotechnology Engineering from the Ecole Supérieure de Biotechnologie de Strasbourg (ESBS) and a PhD in Molecular Biology & Biochemistry from the University of Strasbourg co-directed with the University of Thessaly.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)